NASDAQ
Brii Biosciences Limited (BRIBF) has a price/sales ratio of 52.00x as of Friday, May 22, 2026. This represents a 90.16% decrease compared to its 12-month average of 528.39x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.